Vertex Pharmaceuticals to acquire Alpine Immune Sciences for $4.9 billion

April 11, 2024

Must read

Vertex Pharmaceuticals has agreed to acquire Alpine Immune Sciences for $4.9 billion in cash, bolstering its portfolio on kidney diseases as deals in biotechnology continue to heat up.

Source link

Free Report: An Entrepreneur’s Guide to Understanding and Leveraging Generative AI, Now and in the Future

CPI Report Shows Higher-Than-Expected Inflation in March

Vertex Pharmaceuticals to acquire Alpine Immune Sciences for $4.9 billion

Must read

Recession Odds Surge to 75%: 5 Moves to Make Now

A Reality Check on Private Markets: Part III

Steal These 5 Brilliant Wealth-Building Secrets From the Rich Today

10 Stores Where Coupon Stacking Yields Huge Savings

More articles

LEAVE A REPLY Cancel reply

Latest article

Recession Odds Surge to 75%: 5 Moves to Make Now

A Reality Check on Private Markets: Part III

Steal These 5 Brilliant Wealth-Building Secrets From the Rich Today

10 Stores Where Coupon Stacking Yields Huge Savings

Investing in Real Estate Only Takes $1K With This Bezos-Backed Startup

Usefull Links